Apellis Pharmaceuticals, Inc. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Apellis Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • Apellis Pharmaceuticals, Inc. Return On Equity for the quarter ending June 30, 2024 was -139 %, a 34.7% increase year-over-year.
  • Apellis Pharmaceuticals, Inc. annual Return On Equity for 2023 was -179 %, a 12.8% increase from 2022.
  • Apellis Pharmaceuticals, Inc. annual Return On Equity for 2022 was -205 %, a 96.5% increase from 2021.
  • Apellis Pharmaceuticals, Inc. annual Return On Equity for 2021 was -5.8K %, a 3268% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -179 +26.2 +12.8% Jan 1, 2023 Dec 31, 2023
2022 -205 +5.59K +96.5% Jan 1, 2022 Dec 31, 2022
2021 -5.8K -5.62K -3268% Jan 1, 2021 Dec 31, 2021
2020 -172 +46.5 +21.3% Jan 1, 2020 Dec 31, 2020
2019 -219 -147 -207% Jan 1, 2019 Dec 31, 2019
2018 -71.3 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.